Table 2.
Demographic and clinical characteristics of participants after PSM analysis.
| Characteristics | CHD+NAFLD (n=144) | NAFLD (n=144) | P |
|---|---|---|---|
| BMI (kg/m2) | 26 (24.22, 27.76) | 25.995 (24.385, 28.04) | 0.850 |
| Plt (109/L) | 223.5 (183.75, 268) | 224 (188.75, 258) | 0.887 |
| L (109/L) | 1.885 (1.4775, 2.33) | 1.935 (1.595, 2.3625) | 0.355 |
| M (109/L) | 0.43 (0.35, 0.5325) | 0.475 (0.3675, 0.5525) | 0.286 |
| Cr (mmol/L) | 64 (54, 72) | 66 (56, 75) | 0.449 |
| TC (mmol/L) | 4.3429 ± 1.0494 | 4.369 ± 0.98124 | 0.828 |
| Glu (mmol/L) | 5.345 (4.86, 6.2825) | 5.365 (4.95, 5.8325) | 0.626 |
| Sex (male) | 90 (31.2%) | 79 (27.4%) | 0.188 |
| Age (years) | 59 (51, 66) | 54.5 (48, 62) | 0.006 |
| HT [n (%)] | 93 (32.3%) | 66 (22.9%) | 0.001 |
| DM [n (%)] | 33 (11.5%) | 17 (5.9%) | 0.013 |
| Smoke, n (%) | 64 (22.2%) | 48 (16.7%) | 0.053 |
| N (109/L) | 4.085 (3.2675, 5.1725) | 3.54 (2.7275, 4.78) | < 0.001 |
| TG (mmol/L) | 1.74 (1.3175, 2.3825) | 1.595 (1.17, 2.2) | 0.015 |
| HDL-C (mmol/L) | 1.1072 ± 0.23081 | 1.1859 ± 0.26976 | 0.008 |
| LDL-C (mmol/L) | 2.41 (2.0075, 2.8925) | 2.265 (1.78, 2.715) | 0.030 |
| TyG | 8.95 (8.67, 9.27) | 8.835 (8.53, 9.155) | 0.012 |
| SII | 502.45 (326.84, 680.06) | 417.51 (316.18, 560.56) | 0.006 |
| SIRI | 0.93323 (0.63843, 1.4049) | 0.8698 (0.56531, 1.2157) | 0.045 |
All the above data are expressed as mean ± standard deviation or median (quartiles). The Chi-square test was used for categorical variables.Paired and unpaired t-tests were used for comparison of normal values, and Wilcoxon rank sum test or Mann-Whitney test was used for comparison of non-normally distributed values. p<0.05 was considered statistically significant.
BMI, body mass index; HT, hypertension; DM, diabetes mellitus; Plt, platelet; N, neutrophil; L, lymphocyte; M, monocyte; Cr serum, creatinine; TC, total cholesterol; TG, triglycerides; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; Glu, fasting plasma glucose; TyG, triglyceride-glucose index; SII, immune-Inflammation Index; SIRI, systemic inflammation response index.